ArticlePDF Available

Prevalence and risk factors for dyslipidemia among South Indian adults: A community based-NCD study

Authors:
  • KMCH Research Foundation

Abstract

Background Dyslipidemia is a crucial risk factor for atherosclerotic cardiovascular disease. However, there is limited data available on the differences in the prevalence of dyslipidemia between rural and urban populations in India. The aim of the present investigation is to describe the prevalence of dyslipidemia and the risk factors associated with adverse lipid profiles among adults residing in rural, sub-urban, and urban areas of India, and to assess its association with diabetes and hypertension.Methods We enrolled adults over the age of 20 who lived in three distinct demographic areas in South India: rural, sub-urban, and urban. Data on demographics, lifestyle, disease history, family history, body weight, height, waist circumference, blood pressure, and clinical characteristics were collected for this study. We used chi-square tests and multivariable logistic regression to analyze demographic prevalence and risk factors related to lipid abnormalities among study participants.ResultsThis study enrolled 2976 randomly selected participants from rural, sub-urban, and urban communities in Tamil Nadu, India. Of these, 865 (29.1%) were rural residents, 1030 (34.6%) were sub-urban residents, and 1081 (36.3%) were urban residents. About 80% of women who lived in the suburban area had higher rates of low-HDL cholesterol. Compared to sub-urban (29.9%, 49%, and 21.1%) and rural (33.4%, 43.4%, and 24.1%) populations, urban populations had higher prevalence rates of hypercholesterolemia, hypertriglyceridemia, and elevated LDL-C (37.3%, 52.5%, and 38.6%), respectively. Men were more likely than women to develop dyslipidemia before the age of 40, but after that age, men showed a reduced risk of dyslipidemia than women, except for low HDL cholesterol. Age group, gender, current drinker, overweight, obesity, diabetes, and hypertension showed a significant association (p < 0.05) with dyslipidemia.Conclusions The study found that more than 85% of the sub-urban and urban population had dyslipidemia (at least one lipid abnormality) compared to rural residents (78.5%). The prevalence rates were higher among those with diabetes and hypertension in urban residents.
Vol.:(0123456789)
1 3
International Journal of Diabetes in Developing Countries
https://doi.org/10.1007/s13410-023-01202-7
ORIGINAL ARTICLE
Prevalence andrisk factors fordyslipidemia amongSouth Indian
adults: Acommunity based‑NCD study
SundaresanMohanraj1 · GanesanVelmurugan1· KrishnanSwaminathan2· ArulrajRamakrishnan3
Received: 22 October 2022 / Accepted: 14 April 2023
© The Author(s), under exclusive licence to Research Society for Study of Diabetes in India 2023
Abstract
Background Dyslipidemia is a crucial risk factor for atherosclerotic cardiovascular disease. However, there is limited data
available on the differences in the prevalence of dyslipidemia between rural and urban populations in India. The aim of the
present investigation is to describe the prevalence of dyslipidemia and the risk factors associated with adverse lipid profiles
among adults residing in rural, sub-urban, and urban areas of India, and to assess its association with diabetes and hypertension.
Methods We enrolled adults over the age of 20 who lived in three distinct demographic areas in South India: rural, sub-
urban, and urban. Data on demographics, lifestyle, disease history, family history, body weight, height, waist circumference,
blood pressure, and clinical characteristics were collected for this study. We used chi-square tests and multivariable logistic
regression to analyze demographic prevalence and risk factors related to lipid abnormalities among study participants.
Results This study enrolled 2976 randomly selected participants from rural, sub-urban, and urban communities in Tamil
Nadu, India. Of these, 865 (29.1%) were rural residents, 1030 (34.6%) were sub-urban residents, and 1081 (36.3%) were
urban residents. About 80% of women who lived in the suburban area had higher rates of low-HDL cholesterol. Compared to
sub-urban (29.9%, 49%, and 21.1%) and rural (33.4%, 43.4%, and 24.1%) populations, urban populations had higher preva-
lence rates of hypercholesterolemia, hypertriglyceridemia, and elevated LDL-C (37.3%, 52.5%, and 38.6%), respectively.
Men were more likely than women to develop dyslipidemia before the age of 40, but after that age, men showed a reduced
risk of dyslipidemia than women, except for low HDL cholesterol. Age group, gender, current drinker, overweight, obesity,
diabetes, and hypertension showed a significant association (p < 0.05) with dyslipidemia.
Conclusions The study found that more than 85% of the sub-urban and urban population had dyslipidemia (at least one
lipid abnormality) compared to rural residents (78.5%). The prevalence rates were higher among those with diabetes and
hypertension in urban residents.
Keywords Dyslipidemia· Rural–Urban population· Non-communicable disease (NCD)· Lipid abnormality·
Cardiovascular Risk
Introduction
Atherosclerotic cardiovascular disease (ASCVD) is a major
cause of morbidity and mortality, with a high incidence and
prevalence in low- and middle-income countries. South Asians,
in particular, have a higher risk of ASCVD than other ethnic
populations [1, 2]. In India, the number of prevalent cases of
cardiovascular diseases (CVD) has increased from 25.7 million
in 1990 to 54.5 million in 2016 [3]. Dyslipidemia is one of the
crucial risk factors for CVD and is characterized by any or a
combination of the following: elevated total cholesterol (TC),
raised low-density lipoprotein cholesterol (LDL-C), raised tri-
glycerides (TG), and low high-density lipoprotein cholesterol
(HDL-C) [4]. These adverse lipid profiles are closely linked
to the pathophysiology of atherosclerosis, the key underlying
process contributing to most clinical ASCVD events [5].
According to the 2016 Lipid Association of India report,
the frequency of hypercholesterolemia varies from 10 to
15% in rural to 25% to 30% in urban populations [6]. There
are very few large cohort studies on the epidemiology of
* Sundaresan Mohanraj
mohanraj@kmchrf.org
1 Department ofBiochemistry andMicrobiology, KMCH
Research Foundation, Kovai Medical Center & Hospital,
Coimbatore641014, Tamilnadu, India
2 Department ofEndocrinology, KMCH Research Foundation,
Kovai Medical Center andHospital, Coimbatore, India
3 Department ofGastroenterology, KMCH Research Foundation,
Kovai Medical Center andHospital, Coimbatore, India
International Journal of Diabetes in Developing Countries
1 3
hypercholesterolemia in India [712], but these studies are
not representative of different demographic regions in India.
However, there is limited data available on the prevalence
of lipid abnormalities based on rural versus urban living
in India. Urban–rural differences in adverse lipid profiles
may be prevalent due to several factors such as less physical
activity, high consumption of fast food, and unsaturated fat
intake in urban areas, which may contribute to a higher prev-
alence of dyslipidemia compared to rural areas. The rising
rates of non-communicable diseases (NCD) in both urban
and rural India demonstrate that lifestyles and urbanization
are common but not fully accounted for. Rapid urbaniza-
tion is initiated by urban expansion into peripheral and rural
areas, largely for economic reasons. Although it is not clear
how industrialization or urbanization increases the risk of
metabolic risk factors among people who have had different
early life experiences, several regions of India experience
different climate and geographical conditions due to sub-
stantial latitude and longitude extensions across the country.
However, we could not find any data regarding the sub-
urban population compared with the urban and rural popu-
lations. Therefore, the aim of the present investigation was
to describe the prevalence of dyslipidemia and the risk fac-
tors associated with individual adverse lipid profiles among
adults living in rural, sub-urban, and urban areas in India.
Methodology
Study design A community-based cross-sectional study.
Study sites andpopulation details
Rural‑population details The Nallampatti Panchayat has
population of 3,874 of which 1,929 are males while 1,945
are females as per report released by Census India 2011.
Sub‑urban‑population details The Chinna Thadagam Pan-
chayat has population of 8,407 of which 4,152 are males while
4,255 are females as per report released by Census India 2011.
Urban‑population details The Kalapatti Town Panchayat has
population of 39,586 of which 19,936 are males while 19,650
are females as per report released by Census India 2011.
Study areas
The methodology of the study is described in our earlier
publications (13, 14). In brief, we selected three differ-
ent geographic areas based on contacts with administra-
tive heads, logistics, and the ability to conduct long-term
follow-up. Nallampatti, a typical farming village about
60km from Coimbatore, was chosen as a representative
rural area. Thadagam, an area rich in brick-kilns 15km
from Coimbatore, and Kalapatti, a city within Coimbatore,
were chosen as representative sub-urban and urban areas,
respectively. The individual studies were named Nallam-
patti-NCD study (NNCD), Thadagam-NCD study (TNCD),
and Kalapatti-NCD study (KNCD). The studies were con-
ducted in a staggered pattern over a four-week period in
each area from April 2015 to June 2016. Each study popu-
lation was informed of our visit through the distribution of
leaflets (door to door) and by "word of mouth" through the
local government administrative workers and student volun-
teers. The exclusion criteria included age less than 20years
or greater than 85years, pregnancy, and non-residents of
the selected regions. Age 20years and above and native
residents were included in this study. All three areas had
a defined geographical boundary, and the population data
was collected from the Government of India – Census 2011.
Only the residents of these regions were invited for the study.
The residence of the participants was cross-checked by veri-
fication with the government census data and the proof of
residence documents, such as Aadhar card, voter ID card,
or driving license, provided by the participants. The study
design and protocol were approved by KMCH Ethic Com-
mittee, and informed written consent was obtained from all
participants prior to participation, following the principles
of the Declaration of Helsinki. Collected data were evaluated
on a weekly basis, and feedback was sent to the study team
in the field to correct any discrepancies.
Sample anddata collection fromsub‑urban
andurban regions
We administered a detailed questionnaire, as described
in previous publications [13, 14], to document the educa-
tional status, employment, alcohol intake, smoking status,
pesticide exposure, family disease history, and past medi-
cal history.
Anthropometry
We measured body weight using an electronic weighing
scale (SECA 813), height using a stadiometer (SECA 208),
and waist circumference in centimeters using a non-stretch-
able measuring tape between the costal margins and the iliac
crest at the end of expiration. Blood pressure was recorded
using the electronic OMRON machine in the sitting position
in the right arm (Model HEM-7130, Omron healthcare, Sin-
gapore) on two occasions 15min apart. We used the mean
of the two measurements in analyses. Body mass index was
calculated using the formula weight (kg)/height (m)2.
International Journal of Diabetes in Developing Countries
1 3
Clinical parameters
We prepared serum and plasma samples from whole blood
collected appropriately by standard protocols. HbA1c was
measured using an automated HPLC method (D-10-Biorad),
cystatin-c was determined by Nephlometric method (BN
Prospec-Siemens), glucose was measured using a Hexoki-
nase/ GOD-POD/ endpoint method, and lipid levels were
measured using an automated analyzer (Abbott Architect
ci8200). Uric acid and creatinine levels were measured by
the Endpoint method (Abbott Architect ci8200). Fasting
and post-meal glucose were not considered due to logistical
issues.
Denitions
Dyslipidemia: National Cholesterol Education Programme
(NCEP) [6] guidelines were used for definition of dyslipi-
demia as follows:
Hypercholesterolemia – serum cholesterol lev-
els ≥ 200mg/dl (≥ 5.2mmol/l).
Hypertriglyceridemia – serum triglyceride lev-
els ≥ 150mg/dl (≥ 1.7mmol/l).
Low HDL cholesterol – HDL cholesterol levels < 40mg/
dl(< 1.04mmol/l) for men and < 50mg/dl (< 1.3mmol/l)
for women.
High LDL cholesterol – LDL cholesterol lev-
els 130mg/dl (≥ 3.4 mmol/l) calculated using the
Friedewald equation.
Hypertension was defined as either having a history of
hypertension on medications or a systolic blood pressure
of 140mm Hg and/ or diastolic blood pressure 90mm
Hg on two occasions taken 15min apart, in those without a
history of hypertension.
Overweight was defined as BMI equal to or more than
25kg/m2, and ‘obesity’ as BMI equal to or more than
30kg/m2.
Diabetes was defined as either having a history of diabe-
tes on medications or HbA1c level of 6.5% in those with-
out a history of diabetes.
Statistical analysis
Data were tabulated on Microsoft Excel and transposed
to SPSS for statistical analysis (SPSS) (IBM Corporation,
Armonk, New York, USA). Data were analysed using SPSS
version 20. Chi-square tests and multivariable logistic
regression were performed to found the demographical prev-
alence and risk factors associated with lipid abnormalities
among study participants. We analysed basic characteristics
based the dyslipidemia by study sites (rural vs sub-urban vs
urban) and sex. Prevalence of dyslipidemia in both men and
women were analyzed for three demographic areas. Mean
values of BMI, HbA1c and blood pressure were analysed.
Prevalence of dyslipidemia in diabetes and hypertension
population were analyzed for three demographic areas. Both,
men and women were analysed separately as we anticipated
that there might be sex differences in location (rural, sub-
urban and urban) effects. Multivariable logistic regression
model was used to estimate odds ratios for hypercholes-
terolemia, triglyceridemia, low HDL-C and high LDL-C,
adjusting for age and BMI. A p value < 0.05 was considered
statistically significant.
Results
A total of 2976 participants were enrolled in this study from
rural, sub-urban, and urban communities in Tamil Nadu,
India. Of these, 865 (29.1%) were rural residents, 1030
(34.6%) were sub-urban residents, and 1081 (36.3%) were
urban dwellers. The general characteristics of the study
population based on dyslipidemia are shown in Table1. In
all three demographics, residents with any lipid abnormality
had significantly higher risk factors of BMI, waist circumfer-
ence, HbA1c, total cholesterol, triglycerides, low-HDL, and
high-LDL than those with no lipid abnormality. The mean
age (SD) of rural residents with any lipid abnormality was
significantly higher than that of normal residents (p < 0.05),
whereas sub-urban and urban dwellers did not differ signifi-
cantly between normal and any lipid abnormality residents.
Similarly, the mean values of systolic and diastolic blood
pressure in rural (p = 0.002 and p = 0.05, respectively) and
urban (p = 0.005 and p = 0.002, respectively) residents with
any lipid abnormality were significantly higher than those
with no lipid abnormality, while the sub-urban residents
with any lipid abnormality were not significantly differ-
ent from those with no lipid abnormality. The prevalence
of dyslipidemia (any lipid abnormality) was similar among
sub-urban and urban residents (85.9% vs 86.2%) compared
to rural participants (78.5%). Among the three demograph-
ics, 8.3% (n = 72), 9.1% (n = 94), and 16.4% (n = 177) of
the rural, sub-urban, and urban populations had four lipid
abnormalities, respectively. On the other hand, about 21.5%
(n = 186), 14.1% (n = 145), and 13.8% (n = 149) of the rural,
sub-urban, and urban populations had no lipid abnormali-
ties, respectively. Low HDL-C was the most common dys-
lipidemia, particularly among sub-urban residents (70% vs
58.2% in rural and 68.1% in urban). The dwellers with high
LDL-C were highest in urban areas (38.6%) compared to
sub-urban (21.1%) and rural (24.1%) areas.
International Journal of Diabetes in Developing Countries
1 3
Table 1 Basic characteristics of the study population based on the dyslipidemia
The values are mean (SD) [95%CI]
(One-way ANOVA test was used to compare means of continuous variables between the normal and any lipid abnormality among the three groups (rural, sub-urban and urban))
BMI Body-mass index; SBP Systolic blood pressure; DBP Diastolic blood pressure; HbA1c Heamoglobin A1c; TC Total cholesterol; TGL Triglyceride; L-HDLC Low- high-density lipoproteins;
H-LDLC High- low-density lipoproteins
Rural (n = 865) Sub-urban (n = 1030) Urban (n = 1081) Overall
p Value
Clinical parameters Normal
(n = 186)
Any lipid abnor-
mality (n = 679)
p Value Normal
(n = 145)
Any lipid abnor-
mality (n = 885)
p Value Normal
(n = 149)
Any lipid abnor-
mality (n = 932)
p Value
Age 46.47 (15.39)
[44.25–48.70]
48.79 (13.19)
[47.80–49.79]
.04 51.6 (15.9)
[49.0–54.2]
50.1 (14.4)
[49.1–51.0]
.25 46.5 (17.1)
[43.7–49.3]
48.8 (13.3)
[47.9–49.6]
.06 .002
BMI 21.16 (3.9)
[20.59–21.72]
23.82 (3.97)
[23.53–24.12]
< .001 20.8 (4.3)
[20.1–21.5]
23.9 (5.4)
[23.6–24.3]
< .001 22.0 (4.7)
[21.3–22.8]
25.6 (7.2)
[25.2–26.1]
< .001 < .001
SBP 126.6 (18.3)
[124.0–129.3]
132.08 (21.5)
[130.46–133.7]
.002 128.3 (21.7)
[124.7–131.8]
130.5 (22.3)
[129.1–132.0]
.25 124.0 (23.2)
[120.3–127.8]
129.4 (21.6)
[128.0–130.8]
.005 .074
DBP 80.60 (11.33)
[78.96–82.24]
82.51 (11.9)
[81.61–83.41]
.05 77.7 (12.7)
[75.7–79.8]
78.4 (11.2)
[77.7–79.2)
.52 74.5 (11.8)
[72.6–76.5]
77.8 (11.5)
[77.0–78.5]
.002 < .001
Waist circumference 84.88 (8.71)
[83.6–86.1]
91.07 (9.2)
[90.37–91.7]
< .001 84.36 (11.7)
[82.4–86.3]
90.2 (10.8)
[89.5–91.0]
< .001 85.5 (12.3)
[83.5–87.5]
92.9 (10.0)
[92.3–93.6]
< .001 < .001
Creatinine 0.76 (0.23)
[0.73–0.79]
0.75 (0.18)
[0.74–0.77]
.49 0.71 (.31)
[0.6–0.7]
0.7 (0.3)
[0.6–0.7]
.92 0.8 (0.7)
[0.6–0.9]
0.7 (0.2)
[0.7–0.7]
.09 < .001
HbA1c 5.7 (0.86)
[5.65–5.8]
6.04 (1.16)
[5.95–6.13]
.003 5.8 (1.2)
[5.6–6.0]
6.2 (1.6)
[6.1–6.3]
.001 5.8 (1.1)
[5.6–6.0]
6.2 (1.5)
[6.1–6.3]
.001 < .001
Uric acid 4.4 (1.3)
[4.3–4.6]
4.8 (1.3)
[4.7–4.9]
.001 5.1 (1.5)
[4.8–5.3]
5.2 (1.5)
[5.1–5.3]
.33 4.8 (4.4)
[4.1–5.5]
4.9 (1.3)
[4.8–5.0]
.43 < .001
TC 165.2 (20.5)
[162.2–168.2]
191.2 (40.7)
[188.1–194.3]
< .001 165.3 (22.8)
[161.5–169.1]
186.3 (40.0)
[183.6–188.9]
< .001 164.5 (20.8)
[161.2–167.9]
192.9 (39.3)
[190.4–195.4]
< .001 .003
TGL 88.1 (26.18)
[84.2–91.8]
189.7 (112.1)
[181.3–198.2]
< .001 91.9 (28.4)
[87.2–96.6]
189.8 (106.5)
[182.7–196.8]
< .001 91.8 (29.6)
[87.0–96.6]
198.3 (128.0)
[190.1–206.5]
< .001 .010
L-HDLC 52.5 (7.4)
[51.4–53.6]
41.9 (8.9)
[41.2–42.5]
< .001 51.3 (7.2)
[50.1–52.5]
39.8 (8.5)
[39.2–40.3]
< .001 54.5 (9.5)
[52.9–56.1]
40.2 (9.9)
[39.5–40.8]
< .001 < .001
H-LDLC 93.2 (19.0)
[90.4–96.0]
114.2 (32.6)
[111.8–116.7]
< .001 95.6 (20.2)
[92.2–98.9)
108.6 (33.4)
[106.4–110.8]
< .001 95.9 (18.5)
[92.9–98.9]
125.4 (32.7)
[123.3–127.5]
< .001 < .001
International Journal of Diabetes in Developing Countries
1 3
As shown in Table2, all lipid abnormalities were higher
among women than among men in all three areas of resi-
dence, except for triglycerides. Regarding the four com-
ponents of dyslipidemia, raised triglycerides recorded a
higher prevalence in men compared to women in all three
areas of participants. In sub-urban residences, raised total
cholesterol had a similar prevalence in both men (29.9%;
95% CI 25.8–33.9) and women (29.9%; 95% CI 26.2–33.9),
whereas raised total cholesterol had a higher prevalence in
rural (32.5%; 95% CI 28.2–37.1 for men and 34.2%; 95%
CI 29.8–38.9 for women) and urban settings (36.8%; 95%
CI 32.4–41.6 for men and 37.8%; 95% CI 34.1–41.7 for
women). The prevalence of low levels of HDL-C was higher
in suburban (58.2% for men, 95% CI 53.7–62.7; 80% for
women, 95% CI 76.5–83.2) and urban (58.7% for men, 95%
CI 54.1–63.2; 74.7% for women, 95% CI 70.8–78.1) areas
than in rural areas (52.3% for men, 95% CI 47.7–56.6; 63.8%
for women, 95% CI 59.6–68.4). Similarly, raised LDL-C had
a higher prevalence among urban dwellers (37.9%; 95% CI
33.1–42.7 for men and 39.2%; 95% CI 35.3–42.9 for women)
compared to rural (23.6%; 95% CI 19.8–28 for men and
24.7%; 95% CI 20.9–28.7 for women) and sub-urban popu-
lations (20.5%; 95% CI 17.1–24.1 for men and 21.7%; 95%
CI 18.2–25.3 for women). The mean and standard deviation
values of all lipid abnormalities were highest among the
urban population compared to rural and sub-urban dwellers.
Figure1 presents the prevalence of the four components
of dyslipidemia according to age groups and sex in rural,
sub-urban, and urban residences. Below the age of 40years,
men were more likely than women to have dyslipidemia,
whereas after the age of 40years, men showed a lower risk
of dyslipidemia than women, except for low-HDL choles-
terol. The highest prevalence was observed at the age of
40–59years and declined afterward. In comparison to men,
sub-urban women had an 80% prevalence of low-HDL cho-
lesterol, which was higher in residents of rural and urban
areas. Overall, women had significantly higher rates of lipid
abnormalities than males, except for raised triglycerides,
which was higher in men in all three residences.
Table3 summarizes the lipid abnormalities in residents
with diabetes and hypertension according to the area of resi-
dence. Among the study participants, the prevalence of diabe-
tes was 16.1%, 25.8%, and 23% in rural, suburban, and urban
areas, respectively. Among these participants with diabetes,
the prevalence of high total cholesterol (TC), high triglyc-
erides (TG), high low-density lipoprotein cholesterol (LDL-
C), and low high-density lipoprotein cholesterol (HDL-C)
was 35.3%, 49.6%, 25.2%, and 63.3% among rural dwellers;
34.2%, 62%, 21.4%, and 72.9% among suburban residents; and
41%, 68%, 43.4%, and 72.3% among urban populations. Fur-
thermore, we found that the prevalence of hypertension was
36.4%, 47%, and 39.7% in rural, suburban, and urban areas,
respectively. Among these participants with hypertension,
Table 2 Sex specific prevalence of lipid abnormalities in study participants (Chi-square test)
L-HDLC Low- high-density lipoproteins; H-LDLC High- low-density lipoproteins
Total (n = 2976) Rural (n = 865) Sub-urban (n = 1030) Urban (n = 1081)
Lipid Profile Men
(n = 1322)
Women
(n = 1654)
p value Men
(n = 415)
Women
(n = 450)
p value Men
(n = 469)
Women
(n = 561)
p value Men
(n = 438)
Women
(n = 643)
p value
Count (%) [95% CI]
Hypercho-
lester-
olemia
436(33)
[30.6–35.6]
565(34.2)
[31.9–36.5]
0.262 135(32.5)
[28.2–37.1]
154(34.2)
[29.8–38.9]
0.325 140(29.9)
[25.8–33.9]
168(29.9)
[26.2–33.9]
0.514 161(36.8)
[32.4–41.6]
243(37.8)
[34.1–41.7]
0.390
Hypertri-
glyceri-
demia
727(55)
[52.3–57.7]
722(43.7)
[41.1–46.1]
0.000 211(50.8)
[46.3–55.4]
165(36.7)
[32.2–40.9]
0.000 256(54.6)
[49.9–58.6]
249(44.4)
[40.3–48.8]
0.001 260(59.4)
[54.8–63.7]
308(47.9)
[43.9–51.6]
0.000
L-HDLC 747(56.5)
[53.8–59.3]
1216(73.5)
[71.2–75.6]
0.000 217(52.3)
[47.7–56.6]
287(63.8)
[59.6–68.4]
0.000 273(58.2)
[53.7–62.7]
449(80)
[76.5–83.2]
0.000 257(58.7)
[54.1–63.2]
480(74.7)
[70.8–78.1]
0.000
H-LDLC 360(27.2)
[24.9–29.6]
485(29.3)
[27.1–31.6]
0.112 98(23.6)
[19.8–28]
111(24.7)
[20.928.7]
0.389 96(20.5)
[17.1–24.1]
122(21.7)
[18.2–25.3]
0.336 166(37.9)
[33.1–42.7]
252(39.2)
[35.3–42.9]
0.358
International Journal of Diabetes in Developing Countries
1 3
the prevalence of high TC, high TG, high LDL-C, and low
HDL-C was 35.9%, 54.6%, 24.1%, and 63.2% among rural
dwellers; 36.1%, 56.7%, 25.8%, and 66.8% among suburban
residents; and 43.4%, 58.3%, 44.1%, and 69.7% among urban
populations. Overall, the prevalence of dyslipidemia in par-
ticipants with diabetes and hypertension was highest in sub-
urban and urban areas compared to rural areas.
Table4 describes the results of multivariable logis-
tic regression to identify the risk factors associated with
lipid abnormalities in the study population. After adjust-
ing for age and BMI, hypercholesterolemia was associ-
ated with suburban areas, male gender, age 40–59years,
current drinking, and being underweight. Hypertriglyc-
eridemia was associated with rural areas, male gender,
age 40–59years, current smoking, being underweight,
overweight, diabetes, and hypertension. Low HDL-C was
associated with rural and suburban areas, male gender, cur-
rent smoking, current drinking, being underweight, over-
weight, obesity, and diabetes. High LDL-C was associ-
ated with rural and suburban areas, male gender, and being
underweight or overweight.
Discussion
In the current study, we investigated the prevalence and risk
factors of dyslipidemia among Indian adults aged 20 in
various demographic groups, including rural, sub-urban, and
urban populations. Our findings indicate that more than 85%
of the sub-urban and urban populations had dyslipidemia (at
Fig. 1 Age- and demographic-
specific prevalence of dyslipi-
demia in the study population
0
10
20
30
40
50
20-40 41-60 >60 20-40 41-60 >6020-40 41-60>60
RuralSub-UrbanUrban
%
Age (Years)
HypercholesterolemiaMale
Female
0
10
20
30
40
50
60
70
20-40 41-60 >6020-40 41-60>60 20-40 41-60 >60
Rural Sub-UrbanUrban
%
Age (Years
)
Hypertriglyceridemia Male
Female
0
20
40
60
80
100
20-40 41-60 >60 20-40 41-60>60 20-4041-60 >60
RuralSub-Urban Urban
%
Age (Years)
Low HDL Cholesterol Male
Female
0
10
20
30
40
50
20-4041-60 >6020-40 41-60>60 20-4041-60 >60
RuralSub-Urban Urban
%
Age (Years)
High LDL CholesterolMale
Female
Table 3 Prevalence and
association of dyslipidemia
in diabetic and hypertensive
population (Chi-square test)
*** = p ≤ .001; ** = p ≤ .01; * = p ≤ .05; NS = p > .05; L-HDLC- Low- high-density lipoproteins; H-LDLC-
High- low-density lipoproteins
Diabetic Population (Count and %)
Total
(n = 654/2976)
Rural
(n = 139/865)
Sub-urban
(n = 266/1030)
Urban
(n = 249/1081)
Hypercholesterolemia 242(37)*** 49(35.3)*** 91(34.2)*** 102(41)***
Hypertriglyceridemia 405(61.9)*** 69(49.6)** 165(62)*** 171(68.7)***
L-HDL 462(70.6)*** 88(63.3)NS 194(72.9)NS 180(72.3)**
H-LDL 200(30.6)*** 35(25.2)** 57(21.4)* 108(43.4)***
Hypertensive Population (Count and %)
Total
(n = 1229/2976)
Rural
(n = 315/865)
Sub-urban
(n = 485/1030)
Urban
(n = 429/1081)
Hypercholesterolemia 474(38.6)*** 113(35.9)NS 175(36.1)*** 186(43.4)**
Hypertriglyceridemia 697(56.7)*** 172(54.6)*** 275(56.7)*** 250(58.3)**
L-HDL 822(66.9)NS 199(63.2)* 324(66.8)* 299(69.7)*
H-LDL 390(31.7)*** 76(24.1)NS 125(25.8)*** 189(44.1)**
International Journal of Diabetes in Developing Countries
1 3
least one lipid abnormality), compared to 78.5% of those
living in rural areas. This finding is consistent with a previ-
ous ICMR-INDIAB study that found 76.9% of people in the
Tamil Nadu region had at least one abnormal lipid.
The main findings of our investigation are as follows:
first, the highest prevalence rates of hypercholesterolemia,
hypertriglyceridemia, and high LDL-C were observed in the
urban population compared to sub-urban and rural popu-
lations, respectively. Conversely, L-HDL-C was the most
common dyslipidemia, particularly in sub-urban residents.
Additionally, the middle-aged group (40–59years) had a
higher prevalence of dyslipidemia, particularly among
Table 4 Association of risk factors with dyslipidemia by multivariable logistic regression: age and BMI adjusted
L-HDLC Low- high-density lipoproteins; H-LDLC High- low-density lipoproteins; Dependent variables: Total cholesterol, Triglyceride, Low-
high-density lipoproteins and low-density lipoproteins; Controlling variables: Age and BMI
All demographic data pooled (Odd ratio (95% CI) p Value)
Risk factors Hypercholesterolemia Hypertriglyceridemia Low-HDL High-LDL
Area
Rural 1.069(0.87–1.31) p = .537 1.28(1.04–1.57)p = .017 1.3(1.1–1.65)p = .005 1.8(1.4–2.2)p < .001
Sub-urban 1.29(1.06–1.6) p = .012 1.07(0.88–1.3)p = .47 0.8(0.65–1.0)p = .023 2.1(1.7–2.6)p < .001
Urban 1(ref) 1(ref) 1(ref) 1(ref)
Sex
Male 1.3(1.01–1.6)p = .028 0.67(0.54–0.83)p < .001 2.26(1.8–2.8)p < .001 1.3(1.-1.7)p = .01
Female 1(ref) 1(ref) 1(ref) 1(ref)
Age Groups, years
20–39 1(ref) 1(ref) 1(ref) 1(ref)
40–59 0.70(0.51–1.0)p = .027 0.68(0.51–0.92)p = .013 1.07(0.79–1.5)p = .64 0.87(0.63–1.2)p = .41
≥ 60 1.23(0.72–2.1) p = .458 1.1(0.65–1.8)p = .72 0.96(0.56–1.64)p = .89 1.5(0.84–2.5)p = .17
Education
None 1(ref) 1(ref) 1(ref) 1(ref)
Primary 0.93(0.73–1.2)p = .55 1.0(0.78–1.3)p = .97 1.1(0.9–1.5)p = .20 0.89(0.69–1.14)p = .36
Secondary 1.12(0.88–1.4)p = .33 0.92(0.72–1.16)p = .45 0.87(0.67–1.1)p = .27 1.0(0.78–1.3)p = .87
Degree 0.93(0.69–1.26)p = .66 1.0(0.77–1.4)p = .82 1.12(0.82–1.5)p = .46 0.76(0.55–1.0)p = .08
Employment status
Not-working 1(ref) 1(ref) 1(ref) 1(ref)
Employed 0.94(0.76–1.16)p = .56 0.87(0.71–1.1)p = .16 1.0(0.82–1.2)p = .81 1.0(0.8–1.2)p = .80
Smoking
Non-Smoker 1(ref) 1(ref) 1(ref) 1(ref)
Current Smoker 0.95(0.73–1.23)p = .67 0.73(0.57–0.95)p = .02 0.62(0.48–0.8)p < .001 0.869(0.65–1.14)p = 0.32
Alcohol
Non-drinker 1(ref) 1(ref) 1(ref) 1(ref)
Drinker 0.71(0.55–0.92)p = .01 1.0(0.8–1.3)p = .86 1.4(1.09–1.8)p = .007 0.8(0.61–1.0)p = .11
Tobacco
Non-Chewing 1(ref) 1(ref) 1(ref) 1(ref)
Tobacco chewing 1.0(0.82–1.23)p = .94 1.14(0.94–1.4)p = .19 1.1(0.9–1.3)p = .28 0.96(0.78–1.1)p = .75
BMI Categories
Normal 1(ref) 1(ref) 1(ref) 1(ref)
Underweight 1.81(1.3–2.6)p = .008 3.2(2.3–4.4)p < .001 2.5(1.9–3.4)p < .001 1.8(1.2–2.6)p = .001
Overweight 0.77(0.6–0.98)p = .127 0.62(0.5–0.8)p < .001 0.67(0.53–0.84)p = .001 0.78(0.62–0.98)p = .03
Obesity 1.3(0.8–2.0)p = 0.46 0.9(0.6–1.3)p = .6 0.54(0.34–0.83)p = .006 0.98(0.65–1.4)p = .94
Diabetes
Normal 1(ref) 1(ref) 1(ref) 1(ref)
Diabetes 1.12(0.92–1.37)p = .268 0.66(0.54–0.8)p < .001 0.79(0.64–0.98)p = .03 1.1(0.93–1.4)p = .18
Hypertension
Hypertension 0.85(0.71–1.02)p = .087 0.74(0.62–0.88)p = .001 1.3(0.86–1.2)p = .69 0.88(0.73–1.06)p = .20
Normotensive 1(ref) 1(ref) 1(ref) 1(ref)
International Journal of Diabetes in Developing Countries
1 3
women. Furthermore, we observed higher prevalence rates
in individuals with diabetes and hypertension across all resi-
dence types. Hypercholesterolemia, hypertriglyceridemia,
and high LDL cholesterol were more prevalent in individuals
with diabetes and hypertension residing in urban areas than
in those in rural and sub-urban areas. Moreover, we found
that age group, gender, current drinking habits, overweight
and obesity, diabetes, and hypertension were significantly
associated with dyslipidemia. However, we did not find any
association between education, employment status, tobacco
chewing, and any dyslipidemia.
The prevalence rates in the present study were comparable
to those reported in previous studies. Similar prevalence rates
were reported among Asian Indian immigrants in the United
States (n = 1038) [15], including hypercholesterolemia (43.5%),
hypertriglyceridemia (42.3%), low HDL-C (26.4%), and high
LDL-C (41.4%). The India Heart Watch study (n = 6123)11
reported that the prevalence of hypercholesterolemia was 25.0%
(men 24.8%, women 25.3%), high LDL cholesterol was 15.8%
(men 16.3%, women 15.1%), hypertriglyceridemia was 36.9%
(men 41.2%, women 31.5%), and low HDL cholesterol was
42.5% (men 34.1%, women 53.0%). The recent FitHeart study
(n = 46,919) reported the prevalence of various cholesterol lipo-
protein and triglyceride levels in more than 20 states of India13.
They found that hypercholesterolemia was observed in 26.9%
(men 24.0%, women 30.8%), hypertriglyceridemia in 42.6%
(men 45.6%, women 38.6%), high LDL-C in 60.0% (men
57.6%, women 63.1%), and low HDL cholesterol in 56.0%
(men 49.9%, women 64.5%). Another larger ICMR-INDIAB
study reported that the prevalence of hypercholesterolemia was
found in 13.9%, hypertriglyceridemia in 29.5%, low HDL-C in
72.3%, and high LDL-C in 11.8% of the Indian population12.
Misra etal. [16] used different cut point values in their study
(n = 532). They used hypertriglyceridemia > 200mg/dl and low
HDL-C < 35mg/dl as cut points among adults aged > 25years
in the urban slums of northern India. They reported that the
prevalence of hypercholesterolemia (men 26.8%, women
27.5%), hypertriglyceridemia (men 16.8%, women 12.3%),
low HDL-C (men 15.8%, women 16.7%), and high LDL-C
(men 26%, women 25.4%) was observed. All these studies
reported a low prevalence of hypercholesterolemia compared
to hypertriglyceridemia and low HDL-C, which is similar to
the findings of the present study. These findings suggest that
various components of atherogenic dyslipidemia may be the
more important lipid phenotype in Asian Indians [11]. The low
HDL-C found among sub-urban and urban dwellers was con-
sistent with an earlier report [12] and showed the unhealthy
HDL-C lipid abnormality status among urban populations,
which could put them at risk of coronary artery disease (CAD)
[17]. However, the mean value of low HDL-C was lower in
urban populations compared to rural populations, whereas the
mean cholesterol level was higher in urban than in rural popu-
lations. These results were consistent with previous surveys,
which have also shown higher mean levels of total cholesterol
in urban participants compared to rural participants, with a low
mean level of low HDL cholesterol [18]. The higher prevalence
of low HDL-C may be part of the Asian Indian Phenotype,
which includes increased plasma insulin levels, insulin resist-
ance, increased waist circumference, excess visceral fat, and
low adiponectin levels, as reported by Deepa etal. [18]. Addi-
tionally, urban residence, comparatively less physical activity,
fast food culture, high intake of salt, sugar, and saturated fat
may contribute to the higher prevalence of dyslipidemia. The
prevalence of hypercholesterolemia, hypertriglyceridemia, and
high LDL levels among the rural population was higher than
the findings from an earlier report [12]. Moreover, a recent
review reported that the prevalence of hypercholesterolemia in
the 1990s was 16%, and it has increased to 25–35% among rural
India in recent years [19]. The reasons for these results could
be attributed to the higher prevalence of current smokers and
alcohol consumption among the rural population compared to
sub-urban and urban populations. A previous study estimated
that current smoking might increase the risk of dyslipidemia in
both women and men [20].
On the other hand, Singh etal. [21] reported that the
incidence of hypercholesterolemia was 59%, hypertriglyc-
eridemia was 53%, low HDL-C was 89%, and high LDL-C
was 98% among diabetes patients. However, these preva-
lence rates were higher than those of the present study.
Bali etal. [22] stated that the prevalence of dyslipidemia
in diabetes patients was 81.8%, and among these patients,
hypercholesterolemia was 36.5%, hypertriglyceridemia was
57.2%, high LDL levels were 59.3%, and low HDL was
34.4%. The high LDL-C was much higher than in the pre-
sent study. These above reports were not comparable to the
present study owing to the study population, as ours is a gen-
eral community-based population, but they investigated only
diabetes patients from a single health center. Other studies
have reported diabetes-dyslipidemia as a frequent comorbid-
ity [2325]. Furthermore, the prevalence of dyslipidemia
was high among hypertensive subjects in our study. This
may be owing to dyslipidemia causing endothelial damage,
which can lead to a loss of physiological vasomotor activity
with consequent elevated systemic blood pressure. A previ-
ous report stated that the incidence of dyslipidemia is more
frequent in hypertensive than in normal populations [26].
Also, hypercholesterolemia and hypertension can coexist,
resulting in dyslipidemic hypertension. The above comor-
bidities constitute important risk factors for CVD. Therefore,
appropriate risk assessments and monitoring of serum lipids
among diabetes and hypertensive patients will remain crucial
to reduce the risk of CVD mortality.
In this study, we analyzed the associations between indi-
vidual dyslipidemia and risk factors. After adjusting for age
and BMI, we found that area, gender, and BMI were com-
mon risk factors for all types of dyslipidemia. Participants
International Journal of Diabetes in Developing Countries
1 3
from rural areas showed a significant association with hyper-
triglyceridemia, low HDL-C, and high LDL-C, while sub-
urban participants were associated with hypercholesterolemia,
low HDL-C, and high LDL-C. These findings indicate that
demographic areas tend to have a greater risk of some dys-
lipidemias. The reasons for these associations might be life-
style factors and environmental factors such as exposure to air
pollution [27, 28]. Furthermore, in our study, current smok-
ing, current drinking, BMI, diabetes, and hypertension were
significantly associated with low HDL-C, consistent with
our previous study [12, 29]. Overall, the higher prevalence
of dyslipidemia and its associated risk factors found in this
study suggest that these risk factors play major roles in blood
lipid pathology and must be targeted.
This study builds on previous knowledge about dyslipi-
demia patterns in the Indian population by taking advantage
of a dataset that allows comparisons according to rural, sub-
urban, and urban settings. Several researchers have reported
urban–rural differences in the prevalence of cardiovascular
risk factors and their mortality rates in India. For a country
like India, which contains a large number of small towns
called semi-urban or sub-urban or census towns, which are
very close to major cities (within 10–50km), despite rapid
urbanization, the majority of sub-urban areas in India do not
have facilities for screening and early detection of cardio-
vascular risk factors compared to urban residents. This may
be the first study to report the prevalence of dyslipidemia
in rural, sub-urban, and urban cohorts in India. This study
was based on data from the KMCH-NCD study, which was
conducted among participants from three different regions.
Therefore, its findings may be seen as representative and
convincing. However, several limitations should be consid-
ered. The main limitation of our study is that we used a con-
venience sample rather than a representative sample. In addi-
tion, sociodemographic information was obtained through a
questionnaire, which may lead to recall bias. Furthermore,
the prevalence of dyslipidemia was based on non-fasting
blood samples, and information on lipid-lowering therapy
and non-fasting blood samples was not collected in this
study, which is another limitation. Thus, it is possible that
prevalence rates may be exaggerated due to sampling bias.
However, recently, the lipid association of India reported
that non-fasting lipid concentrations might be a better indi-
cator of average lipid concentrations in the blood than fast-
ing concentrations [6].
Conclusion
This study presents the most recent prevalence of dyslipi-
demia in rural, sub-urban, and urban India, revealing a higher
prevalence of dyslipidemia in urban residents. The middle
age group (40–59years) showed a higher prevalence of
dyslipidemia, with women having a higher prevalence than
men. Hypercholesterolemia, hypertriglyceridemia, and high
LDL cholesterol were more common in urban residents with
diabetes and hypertension compared to rural and sub-urban
residents. Age group, gender, current alcohol consumption,
overweight, obesity, diabetes, and hypertension were identi-
fied as common risk factors for dyslipidemia. These findings
underscore the need for action to more effectively reduce dys-
lipidemia and prevent cardiovascular disease in India. Thus,
appropriate risk assessments and routine monitoring of serum
lipids among patients with diabetes and hypertension will
remain crucial in reducing the risk of CVD mortality.
Acknowledgement This study is funded by the KMCH Research
Foundation in India. We would like to acknowledge Professor Mrs. Dr.
S. Madhavi from the KMCH Nursing College, aswell as Dr. Sujeetha
and Dr. K. Balasubramanian from the KMCH Institute of Allied Health
Sciences, and Dr. Muthusamy (Clinical Biochemist, KMCH). We are
alsograteful to the postgraduates, social workers, and students/staff
from the KMCH Allied Health Science for their contribution to the
conduct of this study,although they had no role in the design, data
interpretation, or manuscript writing.
Data availability On reasonable request, the datasets generated during
this work are available through the correspondences.
Ethical declarations
Ethical approval The study design and protocol received approval from
the KMCH Ethics Committee (Ref. No. NNCD: EC/AP/365/02/2015
(Rural study); TNCD:EC/AP/405/09/2015 (Sub-urban study); KNCD:
EC/AP/464/07/2016 (Urban study)). The study adhered to the princi-
ples outlined in the Declaration of Helsinki.
Informed Consent All participants provided informed written consent
prior to their participation.
Conflict of interest All authors declare no competing interests.
References
1. Enas EA, Garg A, Davidson MA, Nair VM, Huet BA, Yusuf S.
Coronary heart disease and its risk factors in first-generation
immigrant Asian Indians to the United States of America. Indian
Heart J. 1996;48:343–53.
2. Talegawkar SA, Jin Y, Kandula NR, Kanaya AM. Cardiovascular
health metrics among South Asian adults in the United States:
prevalence and associations with subclinical atherosclerosis. Prev
Med. 2017;96:79–84.
3. India State-Level Disease Burden Initiative CVD Collaborators.
The changing patterns of cardiovascular diseases and their risk
factors in the states of India: the Global Burden of Disease Study
1990–2016. Lancet Glob Health. 2018;6(12):e1339–51.
4. Musunuru K. Atherogenic dyslipidemia: cardiovascular risk and
dietary intervention. Lipids. 2010;45(10):907–14.
5. Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones
PH, etal. National Lipid Association recommendations for
International Journal of Diabetes in Developing Countries
1 3
patient-centered management of dyslipidemia: part 1 - executive
summary. J Clin Lipidol. 2014;8:473–88.
6. Iyengar SS, Puri R, Narasingan SN, etal. Lipid Association
of India Expert Consensus Statement on Management of Dys-
lipidemia in Indians 2016: Part 1. J Assoc Physicians India.
2016;64(3 suppl):7–52.
7. Reddy KS, Prabhakaran D, Chaturvedi V, etal. behalf of the Sentinel
Surveillance System for Indian Industrial Populations Study Group:
methods for establishing a surveillance system for cardiovascular
diseases in Indian industrial populations. Bull WHO. 2006;84:461–9.
8. Kinra S, Bowen LJ, Lyngdoh T, etal. Sociodemographic pattern-
ing of noncommunicable disease risk factors in rural India: a cross
sectional study. BMJ. 2010;341:c4974.
9. Shah B, Mathur P. Surveillance of cardiovascular disease risk factors
in India: the need and scope. Indian J Med Res. 2010;132:634–42.
10. Pandey RM, Gupta R, Misra A, etal. Determinants of urban-rural
differences in cardiovascular risk factors in middle-aged women
in India: a cross-sectional study. Int J Cardiol. 2013;163:157–62.
11. Gupta S, Gupta R, Deedwania P, etal. Cholesterol lipoproteins, tri-
glycerides and prevalence of dyslipidemias among urban Asian Indian
subjects: a cross sectional study. Indian Heart J. 2014;66:280–8.
12. Joshi SR, Anjana RM, Deepa M, ICMR-INDIAB Collaborative
Study Group, etal. Prevalence of dyslipidemia in urban and rural
India: the ICMR-INDIAB study. PLos One. 2014;9:e96808.
13. Swaminathan K, Veerasekar G, Kuppusamy S, etal. Noncommu-
nicable disease in rural India: Are we seriously underestimating
the risk? The Nallampatti noncommunicable disease study. Ind J
Endocrinol Metab. 2017;21:90–5.
14. Velmurugan G, Swaminathan K, Veerasekar G, Purnell JQ,
Mohanraj S, etal. Metals in urine in relation to prevalence of
pre-diabetes, diabetes and atherosclerosis in rural India. Occup
Environ Med. 2018;75:661–7.
15. Misra R, Patel T, Kotha P, Raji A, Ganda O, etal. Prevalence of
diabetes, metabolic syndrome, and cardiovascular risk factors in
US Asian Indians: results from a national study. J Diabetes Com-
plications. 2010;24:145–53.
16. Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK, etal.
High prevalence of diabetes, obesity and dyslipidaemia in urban
slum population in northern India. Int J Obes Relat Metab Disord.
2001;25:1722–9.
17. McGill HC Jr, McMahan CA, Malcom GT, Oalmann MC, Strong
JP. Effects of serum lipoproteins and smoking on atherosclerosis
in young men and women. The PDAY research group. Patho-
biological determinants of atherosclerosis in youth. Arterioscler
Thromb Vasc Biol. 1997;17(1):95–106.
18. Deepa R, Sandeep S, Mohan V. Abdominal obesity, visceral fat
and Type 2 diabetes - ‘“Asian Indian Phenotype.”’ In: Mohan V,
Rao GHR, editors. Type 2 diabetes in South Asians: Epidemi-
ology, risk factors and prevention. New Delhi: Jaypee Brothers
Medical Publishers; 2006. p. 138–52.
19. Gupta R, Rao RS, Misra A, Sharma SK. Recent trends in
epidemiology of dyslipidemias in India. Indian Heart J.
2017;69(3):382–92.
20. Lee MH, Ahn SV, Hur NW, Choi DP, Kim HC, Suh I. Gender
differences in the association between smoking and dyslipidemia:
2005 Korean National Health and Nutrition Examination Survey.
Clin Chim Acta. 2011;412:1600–5.
21. Singh G, Kumar AK. A study of lipid profile in type 2 diabetic
Punjabi population. J Exerc Sci Physioth. 2012;8(1):7.
22. Bali K, Vij AK. Pattern of dyslipidaemia in type 2 diabetes mel-
litus in Punjab. Int J Res Med Sci. 2016;4(3):809–11.
23. Expert Panel on Detection E. Adults ToHBCi: executive summary
of the third report of the National Cholesterol Education Program
(NCEP) expert panel on detection, evaluation, and treatment of
high blood cholesterol in adults (adult treatment panel III). JAMA.
2001;285(19):2486–97.
24. Pan L, Yang Z, Wu Y, Yin RX, Liao Y, Wang J, Gao B, Zhang L.
The prevalence, awareness, treatment and control of dyslipidemia
among adults in China. Atherosclerosis. 2016;248:2–9.
25. Wu J, Wang Y, Wang A, Xie J, Zhao X. Association between
fasting triglyceride levels and the prevalence of asymptomatic
intracranial arterial stenosis in a Chinese community-based study.
Sci Rep. 2018;8(1):5744.
26. Thomas F, Bean K, Guize L, Quentzel S, Argyriadis P, Benetos
A. Combined effects of systolic blood pressure and serum choles-
terol on cardiovascular mortality in young (<55 years) men and
women. Eur Heart J. 2002;23(7):528–35.
27. Hata Y, Nakajima K. Life-style and serum lipids and lipoproteins.
J Atheroscler Thromb. 2000;7:177–97.
28. Kunzli N, Jerrett M, Garcia-Esteban R, Basagana X, Beckermann
B, etal. Ambient air pollution and the progression of atheroscle-
rosis in adults. PLoS ONE. 2010;5:e9096.
29. Choudhury SR, Ueshima H, Kita Y, Kobayashi KM, Okayama A,
Yamakawa M, etal. Alcohol intake and serum lipids in a Japanese
population. Int J Epidemiol. 1994;23:940–7.
Publisher's note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.
Springer Nature or its licensor (e.g. a society or other partner) holds
exclusive rights to this article under a publishing agreement with the
author(s) or other rightsholder(s); author self-archiving of the accepted
manuscript version of this article is solely governed by the terms of
such publishing agreement and applicable law.
... The study from south India found that over 85% of the urban population and 78.5% of rural residents have dyslipidaemia. 1 But are we using statin to enough extent to tackle this issue in the young population? In fact, lack of use of risk scores is leading to underutilization and inappropriate dosing of statins. 2 The USPSTF (US Preventive Services Task Force) recommends that clinicians should prescribe a statin for the primary prevention of cerebrovascular disease for adults aged 40 to 75 years who have one or more risk factors for cardiovascular disease (i.e., dyslipidaemia, diabetes, hypertension, or smoking) and an estimated 10-year risk for cardiovascular disease of 10% or greater. 2 If the 10 year cardiovascular risk is 10-19%, besides healthy life-style measures, moderate intensity statins (atorvastatin 10-20 mg/ rosuvastatin 5-10 mg/pravastatin 40-80 mg/ simvastatin 20-40 mg) is recommended. ...
... The study from south India found that over 85% of the urban population and 78.5% of rural residents have dyslipidaemia. 1 But are we using statin to enough extent to tackle this issue in the young population? In fact, lack of use of risk scores is leading to underutilization and inappropriate dosing of statins. 2 The USPSTF (US Preventive Services Task Force) recommends that clinicians should prescribe a statin for the primary prevention of cerebrovascular disease for adults aged 40 to 75 years who have one or more risk factors for cardiovascular disease (i.e., dyslipidaemia, diabetes, hypertension, or smoking) and an estimated 10-year risk for cardiovascular disease of 10% or greater. 2 If the 10 year cardiovascular risk is 10-19%, besides healthy life-style measures, moderate intensity statins (atorvastatin 10-20 mg/ rosuvastatin 5-10 mg/pravastatin 40-80 mg/ simvastatin 20-40 mg) is recommended. ...
... • Severe DR (S-3): More blood vessels get clogged at this stage, resulting in parts of the retina receiving insufficient blood flow [3]. • Proliferative DR (S-4): In this stage, irregular blood vessels in the retina start developing, but they are thin and feeble [9]. ...
Article
Full-text available
Visual disability is increasing due to the incidence of diabetic retinopathy (DR), but timely detection and diagnosis can provide more treatment options and a greater chance of patient survival. Retinal imaging is used for screening and timely detection of the disease. However, determining the exact stage of DR from color retinal fundus images is challenging because they consist of non-uniform lesions with indeterminate extremities. Hence, most of the pre-trained models used in earlier studies to classify retinal images couldn't deliver as expected because these models failed to understand the intricacies of the retinal images. Thus, this work addresses the classification of retinal images (S-0 to S-4) according to the extent of DR using a convolutional neural network (RINet) designed explicitly for retinal fundus images obtained from the APTOS dataset. To improve the classification performance of RINet, features from intermediate layers are extracted, which aid in improvising the model parameters as they indicate the actual state of the model. These extracted features are represented using layer visualization. For disease localization, Gradient-weighted Class Activation Mapping (Grad-CAM) is incorporated at the last convolutional layer, effectively highlighting the crucial regions for every stage in the image. In-depth ablation tests are conducted to realize the current form of the RINet and test its effectiveness. RINet achieves an accuracy of 85% for multi-stage and 95% for binary class on the test set. The simulation results show that the RINet outweighs the pre-trained models, particularly in moderate to severe DR stages.
Article
Full-text available
Dyslipidemia is an abnormality of any lipoprotein fractions (TC, TG, LDL, and HDL). It is important to study the population to monitor risk factors for dyslipidemia and coronary heart disease (CHD). However, few population-based studies related to lipid levels were conducted in Pakistan. In this cross-sectional study, the prevalence of dyslipidemia in the local population (80 participants; 30 females and 50 males) was assessed. The studied population showed abnormalities in at least one lipid fraction including TC, LDL, TG, and HDL. According to abnormal lipid fractions, 89% of the participants were dyslipidemic with more prevalence in the rural population. The gender-wise comparison showed that males were more likely to have dyslipidemia than females due to their abnormal lipid profile. The most common form of dyslipidemia was low HDL (77%), followed by high TG (36%). Various traditionally introduced anthropometric and metabolic parameters were assessed to determine the severity of dyslipidemia, but they were not strong predictors of dyslipidemia due to their limitations. To overcome these limitations, newly introduced anthropometric parameters, namely LBSIZ and the Z-score of ABSI were applied. However, ABSI and its Z-score were also not strong predictors of dyslipidemia.
Article
Non-alcoholic fatty liver disease is a medical burden that is rapidly increasing globally. It is believed to be a complication of metabolic syndrome. It frequently coexists with one or more symptoms of the metabolic syndrome. Metabolic syndrome is closely related to the range of illnesses listed under Santarpanajanya Vyadhi (diseases due to over-nutrition) as per Ayurveda . The conventional medical system has less to offer for treating non-alcoholic fatty liver disease. Ayurveda has tremendous scope in the treatment of these types of diseases. Triphala and Gomutra (cow urine) are reputed drugs in Ayurveda . These are mentioned for treating diseases caused by Santarpana (over-nutrition). Hence, an attempt has been made to review the properties of Triphala and Gomutra (cow urine) to emphasize their utility in treating Santarpanajanya Vyadhi (diseases due to over-nutrition) with special reference to non-alcoholic fatty liver disease. The properties and pharmacological actions of Triphala and Gomutra (cow urine) can be used to manage non-alcoholic fatty liver disease.
Article
Full-text available
Background: The burden of cardiovascular diseases is increasing in India, but a systematic understanding of its distribution and time trends across all the states is not readily available. In this report, we present a detailed analysis of how the patterns of cardiovascular diseases and major risk factors have changed across the states of India between 1990 and 2016. Methods: We analysed the prevalence and disability-adjusted life-years (DALYs) due to cardiovascular diseases and the major component causes in the states of India from 1990 to 2016, using all accessible data sources as part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2016. We placed states into four groups based on epidemiological transition level (ETL), defined using the ratio of DALYs from communicable diseases to those from non-communicable diseases and injuries combined, with a low ratio denoting high ETL and vice versa. We assessed heterogeneity in the burden of major cardiovascular diseases across the states of India, and the contribution of risk factors to cardiovascular diseases. We calculated 95% uncertainty intervals (UIs) for the point estimates. Findings: Overall, cardiovascular diseases contributed 28·1% (95% UI 26·5-29·1) of the total deaths and 14·1% (12·9-15·3) of the total DALYs in India in 2016, compared with 15·2% (13·7-16·2) and 6·9% (6·3-7·4), respectively, in 1990. In 2016, there was a nine times difference between states in the DALY rate for ischaemic heart disease, a six times difference for stroke, and a four times difference for rheumatic heart disease. 23·8 million (95% UI 22·6-25·0) prevalent cases of ischaemic heart disease were estimated in India in 2016, and 6·5 million (6·3-6·8) prevalent cases of stroke, a 2·3 times increase in both disorders from 1990. The age-standardised prevalence of both ischaemic heart disease and stroke increased in all ETL state groups between 1990 and 2016, whereas that of rheumatic heart disease decreased; the increase for ischaemic heart disease was highest in the low ETL state group. 53·4% (95% UI 52·6-54·6) of crude deaths due to cardiovascular diseases in India in 2016 were among people younger than 70 years, with a higher proportion in the low ETL state group. The leading overlapping risk factors for cardiovascular diseases in 2016 included dietary risks (56·4% [95% CI 48·5-63·9] of cardiovascular disease DALYs), high systolic blood pressure (54·6% [49·0-59·8]), air pollution (31·1% [29·0-33·4]), high total cholesterol (29·4% [24·3-34·8]), tobacco use (18·9% [16·6-21·3]), high fasting plasma glucose (16·7% [11·4-23·5]), and high body-mass index (14·7% [8·3-22·0]). The prevalence of high systolic blood pressure, high total cholesterol, and high fasting plasma glucose increased generally across all ETL state groups from 1990 to 2016, but this increase was variable across the states; the prevalence of smoking decreased during this period in all ETL state groups. Interpretation: The burden from the leading cardiovascular diseases in India-ischaemic heart disease and stroke-varies widely between the states. Their increasing prevalence and that of several major risk factors in every part of India, especially the highest increase in the prevalence of ischaemic heart disease in the less developed low ETL states, indicates the need for urgent policy and health system response appropriate for the situation in each state. Funding: Bill & Melinda Gates Foundation; and Indian Council of Medical Research, Department of Health Research, Ministry of Health and Family Welfare, Government of India.
Article
Full-text available
Objective Diabetes and cardiovascular diseases are growing burdens in rural communities worldwide. We have observed a high prevalence of diabetes among rural farming communities in India and sought to evaluate the association of non-traditional risk factors, such as metals, with diabetes and other cardiometabolic risk factors in this community. Methods Anthropometric measurements, chemistries and carotid intima-media thickness were determined in 865 participants of the Kovai Medical Center and Hospital-Nallampatti Non-Communicable Disease Study-I (KMCH-NNCD-I, 2015), a cross-sectional study conducted in a farming village in South India. Urinary metal levels were determined by inductively couped plasma-mass spectrometry analysis and corrected to urinary creatinine level. Statistical analyses were performed to study the association between urinary metal levels and clinical parameters. Results 82.5% of the study population were involved in farming and high levels of toxic metals were detected in the synthetic fertilisers used in the study village. The prevalence of pre-diabetes, diabetes and atherosclerosis was 43.4%, 16.2% and 10.3%, respectively. On logistic regression analysis, no association of traditional risk factors such as body mass index, blood pressure and total cholesterol with disease conditions was observed, but urinary levels of metals such as arsenic, chromium, aluminium and zinc showed an association with diabetes, while arsenic and zinc showed an association with pre-diabetes and atherosclerosis. Conclusions Our data suggest a probable role of metals in the aetiology of diabetes and cardiovascular diseases in rural communities. Identifying and eliminating the causes of increased levels of these environmental chemicals could have a beneficial impact on the burden of non-communicable diseases in rural population.
Article
Full-text available
The aim of this study was to assess the association between fasting triglyceride (FTG) levels and the prevalence of asymptomatic intracranial arterial stenosis (ICAS). The Asymptomatic Polyvascular Abnormalities Community (APAC) study is a sub-population of the Kailuan study which targeting on the epidemiology of asymptomatic polyvascular abnormalities in Chinese adults. A total number of 5345 participants, aged ≥40, and without history of stroke, transient ischemic attack, and coronary heart disease were enrolled in this study. Transcranial Doppler Ultrasonography was performed for the detection of ICAS presence. Out of 5345 participants, 698 subjects diagnosed ICAS (13.1%). In univariate analysis, the association between fasting TG (FTG) levels and asymptomatic ICAS didn’t reach statistical significance (OR: 0.99, 95% CI: 0.89–1.09; P = 0.79), the same conclusion was reached in multivariate analysis, after adjustment for age, sex (OR: 1.05, 95% CI: 0.95–1.17) and age, sex, current smoking status, hypertension, diabetes, body mass index, estimated glomerular filtration rate, total cholesterol, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol (OR: 0.95, 95% CI: 0.84–1.06), respectively. FTG failed to show any statistical significance on ICAS presence in the APAC study, but the TG actually plays an important role in the progression of atherosclerosis as a biomarker.
Article
Full-text available
Dyslipidemia is the most important atherosclerotic risk factor. Review of population based studies in India shows increasing mean total cholesterol levels. Recent studies have reported that high cholesterol is present in 25–30% of urban and 15–20% rural subjects. This prevalence is lower than high-income countries. The most common dyslipidemia in India are borderline high LDL cholesterol, low HDL cholesterol and high triglycerides. Studies have reported that over a 20-year period total cholesterol, LDL cholesterol and triglyceride levels have increased among urban populations. Case-control studies have reported that there is significant association of coronary events with raised apolipoproteinB, total cholesterol, LDL cholesterol and non-HDL cholesterol and inverse association with high apolipoproteinA and HDL cholesterol. Prevalence of suspected familial hypercholesterolemia in urban subjects varies from 1:125 to 1:450. Only limited studies exist regarding lipid abnormalities in children. There is low awareness, treatment and control of hypercholesterolemia in India.
Article
Full-text available
Aim To assess the prevalence of noncommunicable diseases in a true rural farming population in South India and compare the data with the landmark contemporary Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) study. Methods Local Ethics Committee approval and informed consent was obtained from all participants. Inclusion criteria were participants, aged ≥20 and ≤85 years, from Nallampatti, a classical farming village from Tamil Nadu state, India. All participants were administered a detailed questionnaire, had anthropometric measurements including height, weight, and waist circumference. Bloods were drawn for random blood glucose, glycated hemoglobin (HbA1c), nonfasting lipid profile, Cystatin C, uric acid, and hemoglobin. All participants had carotid intima-media thickness (CIMT) done by high-resolution B-mode carotid ultrasound. Results More than 50% of the population had either diabetes or prediabetes based on HbA1c. Nearly, 40% of the population had hypertension with suboptimal control in those with known hypertension. Nearly, a third of the population had dyslipidemia, elevated cystatin C levels, and abnormal CIMT. The burden was higher than the comparable ICMR-INDIAB study in rural Tamil Nadu. Conclusion One-third to one-half of this rural farming population is at risk of cardiovascular disease, with poor control of preexisting cardiovascular risk factors. Current Indian data may underestimate the risk in different ethnic populations and regions of India. Long-term follow-up of this cohort for the incident cardiovascular disease will shed light on the true cardiovascular risk in a typical South Indian rural farming population.
Article
In 2021 an estimated 74 million individuals had diabetes in India, almost all type 2 diabetes. More than half of patients with diabetes are estimated to be undiagnosed and more 90% have dyslipidemia that is associated with accelerated development of atherosclerotic cardiovascular disease (ASCVD). Patients of Indian descent with diabetes have multiple features that distinguish them from patients with diabetes in Western populations. These include characteristics such as earlier age of onset, higher frequency of features of the metabolic syndrome, more prevalent risk factors for ASCVD, and more aggressive course of ASCVD complications. In light of the unique features of diabetes and diabetic dyslipidemia in individuals of Indian descent, the Lipid Association of India developed this expert consensus statement to provide guidance for management of diabetic dyslipidemia in this very high risk population. The recommendations contained herein are the outgrowth of a series of 165 webinars conducted by the Lipid Association of India across the country from May 2020 to July 2021, involving 155 experts in endocrinology and cardiology and an additional 2880 physicians.
Article
South Asians, a fast growing ethnic group in the US, have an increased risk for cardiovascular disease compared to the general population. We examined the prevalence and distribution of the American Heart Association's Life's Simple 7 cardiovascular health (CVH) metrics using data from Mediators of Atherosclerosis in South Asians Living in America (MASALA) study, and cross-sectional associations between number of CVH metrics in the ideal range with subclinical atherosclerosis assessed using coronary artery calcium (CAC) measured using cardiac computed tomography and carotid intima media thickness (CIMT) measured using high-resolution B-mode ultrasonography. CAC was modeled as Agatston scores = 0, 1–400 and > 400; CIMT was examined continuously and as internal CIMT > 1.5 mm. In the MASALA cohort (N = 875; mean age: 55 years; 53% men; living in greater San Francisco and Chicago areas; October 2010–March 2013) without prevalent coronary heart disease, no participant had all 7 metrics in ideal range; approximately 20% of the participants had at least 5 metrics in ideal range. Higher number of CVH metrics in the ideal range was inversely associated with subclinical atherosclerosis. A 1 unit increase in the number of CVH metrics in the ideal range was associated with 32% lower odds of CAC = 1–400 (vs. CAC = 0; OR = 0.68, 95% CI: 0.60, 0.78) and 28% lower odds of internal CIMT > 1.5 mm (OR = 72, 95% CI: 0.61, 0.85). These data show the prevalence of CVH metrics among South Asians in the US, and provide empirical evidence on inverse associations of meeting ideal levels for higher number of metrics and subclinical atherosclerosis.
Article
Objectives: To analyze the prevalence, awareness, treatment, control and epidemiological characteristics of dyslipidemia in Chinese adults. Methods: In this cross-sectional study, we adopted a multi-stage, stratified sampling method to obtain representative samples of the general population aged >18 years from different urban and rural regions in China. All subjects completed a lifestyle and medical history questionnaire and were examined for risk factors. Dyslipidemia was defined according to criteria of the 2007 Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults. Continuous variables were compared using variance analysis. Multivariate logistic regression analysis was performed to explore the risk factors of dyslipidemia. Results: The prevalence of dyslipidemia was 34.0% overall, and 35.1%, and 26.3% in urban and rural areas, respectively. The prevalence of dyslipidemia was significantly higher in men than women (41.9% vs 32.5%; P < 0.001). Rates of awareness, treatment, and control were 31.0%, 19.5%, and 8.9%, respectively. Increasing age (OR = 1.012; 95% CI:1.010, 1.014), male sex (OR = 1.411; 95% CI:1.318, 1.510), obesity (OR = 1.424; 95% CI:1.345, 1.507), cardiovascular disease (OR = 1.343; 95% CI:1.125, 1.603), diabetes (OR = 1.955; 95% CI:1.751, 2.182), hypertension (OR = 1.481; 95% CI:1.391, 1.577) and hyperuricemia (OR = 2.223; 95% CI:2.060, 2.399) were independent risk factors of dyslipidemia. Conclusion: The prevalence of dyslipidemia among Chinese adults was high but awareness, treatment, and control of dyslipidemia were low. Urban high income earners and rural medium income earners show higher prevalence. Low income earners in urban and rural population have the worst awareness treatment, and control rate. There is an increased need for closely monitoring and controlling high risk factors in the populations including postmenopausal women, unhealthy lifestyle peoples and patients with chronic non-communicable diseases.